Genenta Science S p A : Effectiveness of the Amended and Restated OSR License Agreement - Form 6-K
Effectiveness of the Amended and Restated OSR License Agreement As previously disclosed in the Annual Report on Form 20-F for the fiscal year ended December 31, 2022 of Genenta... | May 1, 2023
United States Glaxosmithkline Intellectual Property Development Annual Report Law Decree Solid Cancer Indication Lympho Hematopoietic Indication
Source: marketscreener.com